| Literature DB >> 30824299 |
Kazuma Yagi1, Mari Ushikubo2, Arafumi Maeshima3, Misako Konishi2, Kazuyuki Fujimoto4, Masako Tsukamoto2, Kazuhiro Araki2, Katsuhiko Kamei5, Yoshitaka Oyamada4, Hisaji Oshima2.
Abstract
Aspergillus fumigatus is the commonest cause of pulmonary aspergillosis; however, a recently developed molecular genetic technique identified A. lentulus as a sibling species. Most of the isolates were found in solid organ recipients, often associated with a fatal outcome. Moreover, there is concern that A. lentulus has low susceptibility to multiple antifungal agents. Herein, we report an adult immunocompromised patient with proven invasive pulmonary aspergillosis (IPA) caused by A. lentulus, which was identified through molecular genetic analysis. The patient was diagnosed with IPA by bronchoscopy 3 weeks after initiating systemic corticosteroid therapy for anti-neutrophil cytoplasmic antibody-associated vasculitis. The clinical course of IPA due to A. lentulus showed improvement after treatment with the antifungal agent voriconazole. In summary, we report an adult immunocompromised patient without a history of transplantation who was diagnosed with IPA due to A. lentulus successfully treated with voriconazole, and we also report the findings of a literature review on IPA caused by A. lentulus.Entities:
Keywords: Aspergillus fumigatus; Aspergillus lentulus; Invasive pulmonary aspergillosis
Year: 2019 PMID: 30824299 DOI: 10.1016/j.jiac.2019.02.003
Source DB: PubMed Journal: J Infect Chemother ISSN: 1341-321X Impact factor: 2.211